ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P TSX Capped Composite...
42.48
-0.33%
US Tech 100
21,076.05
-1.27%
S&P 500
5,976.97
-1.13%
US Dollar vs CAD
1.35865
0.00%
Bitcoin
105,787.88
-0.33%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Eli Lilly and Co (LLY) Share Price

Eli Lilly and Co

Eli Lilly and Co (LLY)

Lilly Eli and Co
819.36
7.33
(0.90%)
Closed June 13 3:00PM
15 min delayed - Upgrade to Realtime
818.2687
-1.09
(-0.13%)
After Hours: 6:56PM
15 min delayed - Upgrade to Realtime

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
818.2687
Bid
-
Ask
-
Volume
2,754,599
808.1001 Day's Range 825.00
677.0912 52 Week Range 972.53
Market Cap
775.502B
Previous Close
812.03
Open
810.29
Last Trade
1
@
819.125
Last Trade Time
Financial Volume
US$ 2,258,586,649
VWAP
819.933
Average Volume (3m)
4,093,173
Shares Outstanding
947,735,651
Dividend Yield
0.73%
PE Ratio
73.33
Earnings Per Share (EPS)
11.17
Revenue
45.04B
Net Profit
10.59B

About Eli Lilly and Co

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.lilly.com
Headquarters
Indianapolis, Indiana, USA
Founded
-
Eli Lilly and Co is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker LLY. The last closing price for Eli Lilly was US$812.03. Over the last year, Eli Lilly shares have traded in a share price range of US$ 677.0912 to US$ 972.53.

Eli Lilly currently has 947,735,651 shares outstanding. The market capitalization of Eli Lilly is US$769.59 billion. Eli Lilly has a price to earnings ratio (PE ratio) of 73.33.

Ask ADVFN Intelligence (AI)

Eli Lilly (LLY) Options Flow Summary

LLY Options Flow

Overall Flow

Bullish

Net Premium

32M

Calls / Puts

294.09%

Buys / Sells

106.21%

OTM / ITM

86.80%

Sweeps Ratio

0.43%

LLY Latest News

More News

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
June 06 2025
LLY (0.90%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
May 14 2025
LLY (0.90%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
149.01876.37227169321769.25820.7178765.22889701797.68356075CS
478.268710.5768513514740820.71787093492092752.29670105CS
12-19.0213-2.27176963776837.29902.4999677.09124093173777.4599514CS
2638.26874.90624358974780935.625677.09123863354798.26576058CS
52-50.4113-5.80320716489868.68972.53677.09123638129826.61837572CS
156527.5737181.487022481290.695972.53283.113195955617.50368748CS
260676.2687476.24556338142972.53129.213250877450.20618165CS

LLY - Frequently Asked Questions (FAQ)

What is the current Eli Lilly share price?
The current share price of Eli Lilly is US$ 818.2687
How many Eli Lilly shares are in issue?
Eli Lilly has 947,735,651 shares in issue
What is the market cap of Eli Lilly?
The market capitalisation of Eli Lilly is USD 769.59B
What is the 1 year trading range for Eli Lilly share price?
Eli Lilly has traded in the range of US$ 677.0912 to US$ 972.53 during the past year
What is the PE ratio of Eli Lilly?
The price to earnings ratio of Eli Lilly is 73.33
What is the cash to sales ratio of Eli Lilly?
The cash to sales ratio of Eli Lilly is 17.24
What is the reporting currency for Eli Lilly?
Eli Lilly reports financial results in USD
What is the latest annual turnover for Eli Lilly?
The latest annual turnover of Eli Lilly is USD 45.04B
What is the latest annual profit for Eli Lilly?
The latest annual profit of Eli Lilly is USD 10.59B
What is the registered address of Eli Lilly?
The registered address for Eli Lilly is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204
What is the Eli Lilly website address?
The website address for Eli Lilly is www.lilly.com
Which industry sector does Eli Lilly operate in?
Eli Lilly operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRCLCircle Internet Group Inc
US$ 133.80
(25.59%)
34.01M
NINENine Energy Service Inc
US$ 0.7366
(25.02%)
56.22M
NYCAmerican Strategic Investment Co
US$ 10.50
(12.99%)
1.61k
CNFCNFinance Holdings Limited
US$ 0.4919
(12.28%)
57.31k
SSLSasol Ltd
US$ 5.44
(12.16%)
3.38M
TGEGeneration Essentials Group
US$ 7.3614
(-22.18%)
356.46k
SUPSuperior Industries International
US$ 0.33
(-21.93%)
1.79M
XINXinyuan Real Estate Co Ltd
US$ 2.02
(-18.88%)
15.77k
ACHRArcher Aviation Inc
US$ 9.9899
(-14.83%)
111.01M
PROPros Holding Inc
US$ 15.74
(-13.04%)
2.17M
ACHRArcher Aviation Inc
US$ 9.9899
(-14.83%)
111.01M
BBAIBigBear ai Holdings Inc
US$ 3.715
(-3.00%)
95.9M
FFord Motor Company
US$ 10.44
(-0.85%)
90.11M
BTEBaytex Energy Corporation
US$ 2.09
(3.98%)
73.32M
RIGTransocean Ltd
US$ 3.315
(3.27%)
66.55M

LLY Discussion

View Posts
BottomBounce BottomBounce 3 weeks ago
First, @P_McCulloughMD who is one of the most published people in the world on Covid vaccine myocarditis spoke.

He saw warning signs as early as August of 2021 that the vaccines can cause myocarditis… pic.twitter.com/Gexd9yXOhU— Anna Matson (@AnnaRMatson) May 22, 2025 $LLY
👍️0
BottomBounce BottomBounce 1 month ago
$LLY "This is not a vaccine... It's a genetic experiment at best. And that's without even talking about all the nanotech, just... the biological elements...this is Frankenstein science... [and before COVID] less than 400 humans were ever experimented with with MRNA."

Dr. Mark Trozzi… pic.twitter.com/eBB4NOa3I8— Sense Receptor (@SenseReceptor) May 14, 2025 LLY
👍️0
TechandBio TechandBio 1 month ago
GSK pays 2 Billion for Boston Pharma a IV LLY should scoop up SGMT the oral with the breakthrough designation.

MDGL just partnered with SGMT combining one oral tablet makes MDGL THR Beta work 80% compared to 25% alone Plus works incredibly well with GLP1 data with semaglutide & SGMT oral enhanced efficacy tremendously with SGMT Fatty synthesis the only one in the clinic world wide. SGMT has breakthrough designation for their phase 3 ready Mash Trials and Pediatric Mash the only in the clinic phase 2 Ready for Pediatric


$LLY
👍️0
Saving Grace Saving Grace 1 month ago
The pump before the dump! Look out below. Super cave Tuesday coming.
👍️0
BottomBounce BottomBounce 1 month ago
So many children are getting cancer, yet, no one wants to consider vaccines as the culprit.

This needs to change. @RobertKennedyJr @POTUS pic.twitter.com/ZvK4IgS2T5— Died Suddenly (@DiedSuddenly_) May 10, 2025 $LLY
👍️0
BottomBounce BottomBounce 1 month ago
$LLY Total Debt (mrq) $34.91B
👍️0
Monksdream Monksdream 2 months ago
LLY, 10Q due 5/1
👍️0
makinezmoney makinezmoney 2 months ago
$LLY: Those 4/17 $800calls ..... PURE GENIUS.... up 535,900%

JUST ON THE DAY !!!!!!!!!!!!!


You wanna hit the LOTTERY on the OPTIONS MARKET................ THATs HOW YOU EFFIN DO !!!!!!!!!

This has to be the biggest INTRADAY Options YIELD I have EVER SEEN.

I don't think the days of seeing a 1Million% yield are far off now............ That is going to make someone AN INSTANT BILLIONAIRE !!!!!

I can't believe more people aren't talking about this here.

Completely MIND BLOWING.... everyone out there pumping their PENNY STOCKS while this is how you make that EZ MONEY baby.


These wkly $800 calls were only $0.01 yesterday............. right now they are at $53.60 !!!!!!!!!!!!

0dte calls are HYPERACTIVE MONEY MAKERS if you know you're crap and there were clearly some loaders on this YESTERDAY as you can see the volume activity on this chart.

This news came out at 6am EST today but you can see from yesterdays activity, there
were insiders and their friends that were clearly ahead of the game and were already positioning
themselves in on these.

https://www.prnewswire.com/news-releases/lillys-oral-glp-1-orforglipron-demonstrated-statistically-significant-efficacy-results-and-a-safety-profile-consistent-with-injectable-glp-1-medicines-in-successful-phase-3-trial-302430985.html



GO $LLY
👍 2
double_m double_m 2 months ago
And who says buying the dip was a bad idea. I love this stock!!! 🚀
👍️0
makinezmoney makinezmoney 2 months ago
$LLY: Amazing 560k % YIELD on those $800wkly calls !!!!!!!!!!!!!!




GO $LLY
👍️0
BottomBounce BottomBounce 2 months ago
$LLY Total Debt (mrq) $34.91B Pump and Dump Scam stock https://www.cnbc.com/2025/03/31/vaccine-stocks-fall-after-fdas-peter-marks-resigns-over-rfk-jr.html
👍️0
TechandBio TechandBio 3 months ago
Back in option play up 24% in a week for July

$LLY
👍️0
BottomBounce BottomBounce 5 months ago
Eli Lilly and Company $LLY Total Debt (mrq) $31.23B Massive debt compared to dwinding cash. Pump and dump
👍️0
peanutz peanutz 5 months ago
Another gloom and doomer . Lilly is fine . I worked there over 10 years and they have a ton in the pipeline . It needs a breather . Crash my a$$
👍️0
MartinLutherKing MartinLutherKing 5 months ago
RNAZ micro rna cancer cure ELAB el-22 obesity target buyout in progress
👍️ 1
MomsSpaghetti MomsSpaghetti 6 months ago
Are you saying small biotech has a chance...? I was thinking the other way...

Eli Lilly has been a major player in CNS disorders, particularly with treatments for depression (e.g., Prozac) and schizophrenia. They are actively exploring new areas in psychiatry, including the potential for psychedelics.

Lilly has shown interest in novel treatments for depression and anxiety and has partnered with companies in the psychedelic space. Their expansion into the psychedelic field could be an opportunity to leverage MindMed's expertise in developing treatments using substances like LSD and MDMA.

I am wondering if they (or others) would might possibly acquire them.
👍️0
fung_derf fung_derf 7 months ago
I've been waiting and waiting for this one to pull back and it has. However, it is fighting mightily to hold support here....Right now I'm thinking it looks moderately hopeful here, but I think $NVO has become the better play now.
👍️0
Saving Grace Saving Grace 7 months ago
Industry changing direction. Big Pharma going south! LLY a major short candidate going into 2025.
👍️0
TechandBio TechandBio 8 months ago
$1000 strikes for Jan 2025 look juicy.

$LLY
👍️0
uksausage uksausage 8 months ago
why?
👍️0
Saving Grace Saving Grace 8 months ago
Big Pharma to crash hard. Be prepared!
👍️0
TechandBio TechandBio 9 months ago
Wonder if Lily Buys SMMT.
$LLY
👍️0
DewDiligence DewDiligence 10 months ago
LLY offers Zepbound in_single-use_vials_at_sharply_reduced_prices—(yesterday’s news):

https://www.nytimes.com/2024/08/27/well/eli-lilly-zepbound-price.html On Tuesday, Eli Lilly announced that it would start selling low doses of its weight-loss drug Zepbound in vials… — at a far lower price than its pens, which come with pre-filled doses. These vials will be made available only through LillyDirect, a telehealth platform the company launched in January (https://investor.lilly.com/news-releases/news-release-details/lilly-launches-end-end-digital-healthcare-experience-through ).

…The vials are significantly cheaper than Zepbound pens, which cost just over $1,000 a month without insurance. A month’s supply of the 2.5-milligram dose will cost $399, and a month’s worth of the five-milligram dose will cost $549.

… The company will offer vials with only the two lowest doses of Zepbound. Many patients stay on a five milligram dose… but some gradually increase their dose, up to a maximum of 15 milligrams. Any patient interested in taking more than the five-milligram dose would have to transition to the pens.

…the move could help Lilly regain customers who are currently getting compounded tirzepatide, which typically costs between roughly $250 and $450 a month. Why would anyone want a compounded formulation of tirzepatide derived from Chinese API when they can get the real thing from LLY at close to the same price?
👍️0
Monksdream Monksdream 10 months ago
LLY new 52=week high
👍️0
EnchantedTitan62 EnchantedTitan62 10 months ago
To quote Areosmith ' I'm back in the saddle again' . 💰
👍️0
EnchantedTitan62 EnchantedTitan62 10 months ago
In the green premarket again. 🍷
👍️0
EnchantedTitan62 EnchantedTitan62 10 months ago
Bought back in at open today. 🍷
👍️0
EnchantedTitan62 EnchantedTitan62 10 months ago
In regards to new a pharma product.
👍️0
Zardiw Zardiw 10 months ago
$LLY Chart from #DDAmanda - #1 Stock Screener :



Z
👍️0
EnchantedTitan62 EnchantedTitan62 10 months ago
Just sold my LLY shares. Wonderful way to ease into the weekend. Good luck to everyone today.
👍️0
EnchantedTitan62 EnchantedTitan62 10 months ago
Added @ $866.29
👍️0
EnchantedTitan62 EnchantedTitan62 10 months ago
Going to be another green day.
👍️0
EnchantedTitan62 EnchantedTitan62 10 months ago
I don't think they have sales in Europe yet, that'll change. 💰💰💰
👍️0
EnchantedTitan62 EnchantedTitan62 10 months ago
Uh, probably not .
👍️0
Monksdream Monksdream 11 months ago
LLY new 52=week high
👍️0
EL Sueno EL Sueno 11 months ago
Let's go fans 1000.00!!!
👍️0
Monksdream Monksdream 12 months ago
LLY new 52 week high
👍️0
Monksdream Monksdream 12 months ago
LLY new 52 week high
👍️0
Monksdream Monksdream 1 year ago
LLY 10Q due 4/30
Next day setttlement begins 5/28
👍️0
north40000 north40000 1 year ago
FDA advises LLY it wants AdCom meeting. Portends delay. Meanwhile NVO CEO was interviewed on CNBC-TV this morning, repeats NVO’s PR warning dated in January 2024 that it will not have manufacturing capacity to fill demand for its weight loss drug until 2006(?).
👍️0
Alfonz66 Alfonz66 1 year ago
Sell now boys you had a great run
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high

👍️0
oldstocks oldstocks 1 year ago
Eli Lilly was investigating Talampanel prior to 2010

For the treatment of epilepsy, malignant gliomas and ALS
development codes LY-300164 , LY300164
results from the trial for ALS have been found negative
Talampanel is not currently under development.
It showed effectiveness for epilepsy in clinical trials but its development was suspended due to its poor pharmacokinetic profile, namely a short terminal half-life (3 hours) that necessitated multiple doses per day.
RespireRx Pharmaceuticals $ RSPI a little unknown company KRM–II–81 has shown promising results for Epilepsy.
Has fully suppressed the epileptiform activity in the excised brain tissue from a 19-year-old patient with pharmaco-resistant epilepsy.
👍️0
ralphey ralphey 1 year ago
I bought Lilly about a year ago based on Mounjaro and knowing it was going to be a success. I am a FAmily Doc who has done bariatric medicine for 30 years. Zepbound definitely is inducing more weight loss than Ozempic (Wegovy) but I am getting concerned over the number of patients that are stopping zepbound / Mounjaro due to side effects, seems a lot more than on Ozempic ( Wegovy) .
👍️0
Monksdream Monksdream 1 year ago
Incredible, isn’t it
What gets me about these social media bozos is they actually believe they will become Boca Raton rich by day trading sub $1 stocks
Because they are incapable of researching companies
🌈 1 🍆 1
vinsterr vinsterr 1 year ago
800$ tomorrow?
👍️0
Monksdream Monksdream 1 year ago
LLY new 52=week high
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0

Your Recent History

NYSE
LLY
Eli Lilly
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads